These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22167231)

  • 1. Non-parametric estimation of relative risk in survival and associated tests.
    Wakounig S; Heinze G; Schemper M
    Stat Methods Med Res; 2015 Dec; 24(6):856-70. PubMed ID: 22167231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estimation of average hazard ratios by weighted Cox regression.
    Schemper M; Wakounig S; Heinze G
    Stat Med; 2009 Aug; 28(19):2473-89. PubMed ID: 19472308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression models for the restricted residual mean life for right-censored and left-truncated data.
    Cortese G; Holmboe SA; Scheike TH
    Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing a new estimator and test for the weighted all-cause hazard ratio.
    Ozga AK; Rauch G
    BMC Med Res Methodol; 2019 Jun; 19(1):118. PubMed ID: 31185922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
    Cho Y; Ghosh D
    PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval estimation of the proportion ratio under multiple matching.
    Lui KJ
    Stat Med; 2005 Apr; 24(8):1275-85. PubMed ID: 15565736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?
    Rauch G; Brannath W; Brückner M; Kieser M
    Methods Inf Med; 2018 May; 57(3):89-100. PubMed ID: 29719915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
    Schaubel DE; Wei G
    Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eight interval estimators of a common rate ratio under stratified Poisson sampling.
    Lui KJ
    Stat Med; 2004 Apr; 23(8):1283-96. PubMed ID: 15083483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented and doubly robust G-estimation of causal effects under a Structural nested failure time model.
    Mertens K; Vansteelandt S
    Biometrics; 2018 Jun; 74(2):472-480. PubMed ID: 28742252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-sample tests for survival data from observational studies.
    Li C
    Lifetime Data Anal; 2018 Jul; 24(3):509-531. PubMed ID: 28849359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential tests for non-proportional hazards data.
    Brückner M; Brannath W
    Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Mantel-Haenszel estimators for K 2 x J tables.
    Greenland S
    Biometrics; 1989 Mar; 45(1):183-91. PubMed ID: 2720051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frailty models and rank tests.
    Oakes D; Jeong JH
    Lifetime Data Anal; 1998; 4(3):209-28. PubMed ID: 9787603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of a common effect parameter from sparse follow-up data.
    Greenland S; Robins JM
    Biometrics; 1985 Mar; 41(1):55-68. PubMed ID: 4005387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
    Austin PC
    Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust semi-parametric warping estimator of the survivor function with an application to two-group comparisons.
    Hutson AD
    Stat Methods Med Res; 2018 Feb; 27(2):384-397. PubMed ID: 26988931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating net survival: the importance of allowing for informative censoring.
    Danieli C; Remontet L; Bossard N; Roche L; Belot A
    Stat Med; 2012 Apr; 31(8):775-86. PubMed ID: 22281942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.